Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - United Kingdom
Summary - Nhs National Transition Framework For Apremilast, Pazopanib And Dapagliflozin
Deadline - Sep 03, 2026
GT reference number - 117113191
Product classification - Pharmaceutical products
Address - United Kingdom
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 117113191
Document Type - Tender Notices
Description - Description: Project title: NHS National Framework for Transition Products (Apremilast, Pazopanib and Dapagliflozin) commencing 1st February 2026Offer reference number: CM/TNS/25/5735Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.Potential periods of call-offs under the framework agreement:CM/TNS/25/5735 Apremilast, Pazopanib and DapagliflozinLot 1 DLN/DNW: 01/02/2026 to 31/01/2027 (12 months)Lot 2 DLS/DNE: 01/02/2026 to 31/01/2027 (12 months)Lot 3 DCE/DSW: 01/02/2026 to 30/09/2027 (20 months)Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS Engla
Gt Ref Id - 117113191
Deadline - Sep 03, 2026
View more tenders for
Pharmaceuticals Tenders Pharmaceutical products Tenders United Kingdom TendersSimilar Tenders :
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database